| 标题 |
A Phase 2, Randomized, Double-Blind, Multicenter Study of Telitacicept for Injection (RC18) With an Optional Open Label Extension in Subjects With IgA Nephropathy
|
| 备注 |
https://clinicaltrials.gov/study/NCT04905212 https://manisheynless.5299.info/search/results?subaction=viewrecord&id=LNCT04905212&from=export
💡 该求助存在备注,如果存在信息冲突,请以备注为准
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 其它 | 2021 Report Number: Phase 2 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)